Clinical Trials Logo

Clinical Trial Summary

To estimate probabilities of death by cause for a representative United States population, according to age, sex, race, occupation, industry, income, education, residence, country of birth, calendar year, and a number of other demographic and epidemiologic factors. The representative population is derived from selected Bureau of the Census files and is matched to the National Death Index maintained by the National Center for Health Statistics. The Bureau of the Census provides the data processing, coding and management necessary to complete this objective.


Clinical Trial Description

BACKGROUND:

The current National Longitudinal Mortality Study began in 1983 with agreements with the Census Bureau which prepared baseline files from surveys representative of the United States and with the National Center for Health Statistics which prepared the National Death Index identifying deaths in the baseline populations. The baseline population of over one million persons has been matched to the NDI on several occasions, resulting in approximately 100,000 deaths occurring in 1979 to 1989. Using available data, an analysis was conducted relating socio-economic characteristics to subsequent mortality.

DESIGN NARRATIVE:

The NLMS is a national study of mortality over time among selected Census Bureau population samples numbering about 2.4 million. The census samples are matched to the National Death Index (NDI) maintained by the National Center for Health Statistics. The NDI is a file of all U.S. deaths since 1979 and is used to determine which individuals in the Current Population Surveys (CPS) have died. The samples are matched every other year to obtain deaths among these cohorts. Death certificates are then purchased from the states and coded for causes of death and other data. Mortality rates by age, sex, race, national origin, occupation, industry, income, education, state of residence and other factors are then obtained. The follow-up period begins with 1979, the first year covered by the NDI and ends with 1998. The total number of deaths for these cohorts is estimated to be about 250,000.

Census samples in the NLMS are being matched to the Centers for Medicare & Medicaid Services (CMS) medicare database. Hospitalization, physician, outpatient, and other CMS data will be incorporated into the NLMS database for all participants meeting the Medicare age eligibility criteria. The study continues through December, 2009. ;


Study Design

N/A


Related Conditions & MeSH terms


NCT number NCT00005159
Study type Observational
Source National Heart, Lung, and Blood Institute (NHLBI)
Contact
Status Completed
Phase N/A
Start date July 1983
Completion date December 2009

See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)